A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
Clinical trial NCT06818968 · COMPLETED
Trial details
- NCT number
- NCT06818968
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-27
- Primary completion
- 2025-08-08
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.